AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED Financials Aesthetic Medical International Holdings Group Limited
Equities
AIH
US00809M1045
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4243 USD | -1.35% |
|
+14.58% | -38.47% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 1,055 | 812 | 521.6 | 273.2 | 232.5 |
| Enterprise Value (EV) 1 | 1,181 | 1,186 | 858.2 | 654.1 | 414.8 |
| P/E ratio | -19.2 x | -3.18 x | -0.83 x | -3.19 x | -5.83 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 1.21 x | 0.9 x | 0.81 x | 0.41 x | 0.34 x |
| EV / Revenue | 1.36 x | 1.32 x | 1.33 x | 0.98 x | 0.61 x |
| EV / EBITDA | 54.9 x | -8.15 x | -3.1 x | 67.7 x | 24.3 x |
| EV / FCF | 9.2 x | -27.2 x | 4.86 x | -76.9 x | -43.2 x |
| FCF Yield | 10.9% | -3.67% | 20.6% | -1.3% | -2.31% |
| Price to Book | 1.93 x | 2.08 x | -3.33 x | -2.45 x | 4.72 x |
| Nbr of stocks (in thousands) | 23,613 | 23,613 | 23,598 | 30,706 | 47,512 |
| Reference price 2 | 44.69 | 34.39 | 22.11 | 8.897 | 4.894 |
| Announcement Date | 4/30/20 | 4/30/21 | 5/16/22 | 4/21/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 761.3 | 869 | 901.6 | 645.6 | 670.1 | 682.6 |
| EBITDA 1 | 85.58 | 21.51 | -145.5 | -276.8 | 9.668 | 17.08 |
| EBIT 1 | 53.73 | -16.3 | -196.5 | -342.2 | -21.27 | -48.81 |
| Operating Margin | 7.06% | -1.88% | -21.79% | -53% | -3.17% | -7.15% |
| Earnings before Tax (EBT) 1 | -234 | 152.4 | -259.5 | -681.3 | -94.17 | -55.06 |
| Net income 1 | -255.2 | 136.3 | -235.5 | -586.6 | -76.25 | -37.43 |
| Net margin | -33.53% | 15.68% | -26.12% | -90.87% | -11.38% | -5.48% |
| EPS 2 | -18.66 | -2.328 | -10.83 | -26.68 | -2.793 | -0.8400 |
| Free Cash Flow 1 | -40.9 | 128.3 | -43.55 | 176.7 | -8.511 | -9.59 |
| FCF margin | -5.37% | 14.76% | -4.83% | 27.37% | -1.27% | -1.4% |
| FCF Conversion (EBITDA) | - | 596.26% | - | - | - | - |
| FCF Conversion (Net income) | - | 94.11% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 7/1/19 | 4/30/20 | 4/30/21 | 5/16/22 | 4/21/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 685 | 125 | 374 | 337 | 381 | 182 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 8.002 x | 5.826 x | -2.572 x | -1.216 x | 39.4 x | 10.67 x |
| Free Cash Flow 1 | -40.9 | 128 | -43.6 | 177 | -8.51 | -9.59 |
| ROE (net income / shareholders' equity) | 186% | 81.1% | -48.6% | -560% | 48.7% | 86.6% |
| ROA (Net income/ Total Assets) | 5.35% | -1.18% | -11.8% | -26.5% | -2.37% | -5.51% |
| Assets 1 | -4,768 | -11,535 | 1,999 | 2,215 | 3,222 | 679.2 |
| Book Value Per Share 2 | -20.00 | 23.20 | 16.60 | -6.630 | -3.630 | 1.040 |
| Cash Flow per Share 2 | 7.310 | 6.540 | 1.880 | 1.660 | 0.3900 | 1.320 |
| Capex 1 | 45.5 | 69.1 | 38.4 | 33.2 | 1.6 | 55.2 |
| Capex / Sales | 5.98% | 7.95% | 4.25% | 5.15% | 0.24% | 8.09% |
| Announcement Date | 7/1/19 | 4/30/20 | 4/30/21 | 5/16/22 | 4/21/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -38.47% | 20.43M | |
| -17.07% | 16.21B | |
| +3.60% | 12.44B | |
| +5.64% | 11.58B | |
| +4.63% | 10.79B | |
| +25.58% | 8.26B | |
| -0.21% | 7.68B | |
| +22.18% | 7.06B | |
| +5.20% | 6.67B | |
| +52.00% | 4.66B |
- Stock Market
- Equities
- AIH Stock
- Financials Aesthetic Medical International Holdings Group Limited
